Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Nicholson

Sports Medicine Chicago, IL Medical Doctor

NPI 1477532141 CMS profile 293887

1611 W Harrison St, Ste, Chicago, IL 60612

Open in the dashboard

General payments

$6,715,019

395 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gregory Nicholson of Chicago, IL is reported in the CMS Open Payments database as having received $6,715,019 across 395 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,742,498 41
2024 General $1,432,676 28
2023 General $1,186,436 82
2022 General $877,944 68
2021 General $617,486 61
2020 General $433,120 36
2019 General $424,860 79

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Nicholson
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Gregory Nicholson were reported at $1,742,498. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Gregory Nicholson Sports Medicine median Middle half National median
2019 $424,860 $1,176 $199–$4,249 $163
2020 $433,120 $708 $96–$2,890 $114
2021 $617,486 $1,213 $152–$3,994 $132
2022 $877,944 $1,230 $159–$3,998 $149
2023 $1,186,436 $584 $146–$2,836 $160
2024 $1,432,676 $628 $163–$3,168 $164
2025 $1,742,498 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $5,692,409 229 payments
  2. Wright Medical Technology, Inc. $808,892 85 payments
  3. Anika Therapeutics, Inc. $139,131 38 payments
  4. Arthrosurface Incorporated $69,683 26 payments
  5. KCI USA, Inc $2,179 4 payments
  6. AzurMeds, Inc. $1,905 3 payments
  7. Exactech, Inc. $158 1 payment
  8. Responsive Arthroscopy LLC $152 1 payment
  9. Smith+Nephew, Inc. $149 1 payment
  10. Encore Medical, LP $121 1 payment
  11. Other $241 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $6,410,646 92 payments
  2. Consulting Fee $257,600 122 payments
  3. Travel and Lodging $25,066 74 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,350 10 payments
  5. Food and Beverage $7,357 97 payments
Products named General payments · program years 2019–2025
  1. AEQUALIS PERFORM $5,544,466 62 payments
  2. AEQUALIS $747,839 20 payments
  3. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $138,860 132 payments
  4. OVOMotion Orthopedics $71,367 17 payments
  5. HemiCAP Shoulder $69,749 23 payments
  6. TORNIER PERFORM REVERSED GLENOID $42,492 16 payments
  7. REUNION $32,192 4 payments
  8. AEQUALIS PERFORM+ $25,504 4 payments
  9. Ovomotion Orthopedic $24,932 4 payments
  10. AEQUALIS PERFORM REVERSED $24,606 6 payments
  11. Other $221,323 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

322

Median for Sports Medicine: 144

Drug cost

$2,006

Median for Sports Medicine: $1,027

Branded share of claims

0%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 179 $1,197
Methylprednisolone Generic 75 $362
Celecoxib Generic 16 $326
Meloxicam Generic 26 $72
Amoxicillin Generic 26 $48

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$255,604

Of which drugs: $929

Medicare patients

639

Average age 74

Services billed

3,623

364 women, 275 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Ischemic heart disease 28%
Depression 22%
Osteoporosis 21%
Diabetes 20%
Atrial fibrillation 18%
Cancer 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 129 1,221 $914

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

395 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record